Melbourne-based biotech Starpharma could play a key role in halting the sexual transmission of the dreaded Zika virus, which can cause serious complications for babies in utero.
The mosquito-borne Zika virus has spread in Brazil, where about a million people have been infected, and has hit more than 40 other countries in the Americas, Caribbean, and the Pacific.
Loading...
Tim Binsted writes on Business specialising in Agriculture, Construction, Manufacturing. Tim is based in our Sydney newsroom. Connect with Tim on Twitter.
